CUV 1.04% $15.23 clinuvel pharmaceuticals limited

Ann: New case of SCENESSE efficacy in vitiligo presented at AAD, page-12

  1. 20 Posts.
    lightbulb Created with Sketch. 2
    “The USA vitiligo trial is powering on. Those recent patient data are in one word impressive. Cuv is training and certifying vitiligo centers for a reason. They must be very confident that the fda will approve scenesse for vitiligo.”

    I didn’t know they were training and certifying vitiligo centres. Was that announced officially?

    Would these centres be in the same location as the EPP ones?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.23
Change
-0.160(1.04%)
Mkt cap ! $763.0M
Open High Low Value Volume
$15.39 $16.02 $15.22 $2.031M 129.6K

Buyers (Bids)

No. Vol. Price($)
1 186 $15.22
 

Sellers (Offers)

Price($) Vol. No.
$15.36 646 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.